Corporacio Sanitaria Parc Tauli

Sabadell, Catalonia 08208

0 studies enrolling now · 4 studies all time

What they study most

Active Systemic Lupus Erythematosus, Acute Kidney Injury, Colorectal Cancer, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma

Studies at this site

• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed
• Efficacy and Safety of Efavaleukin Alfa in Subjects With Active Systemic Lupus Erythematosus — Stopped early
• A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI — Completed
• A Study Combining mFOLFOX6 With Tivozanib or Bevacizumab in Patients With Metastatic Colorectal Cancer as First Line Therapy — Completed